Is Welcure Drugs And Pharmaceutic a good stock to invest in?

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics - TTM P/E: 5.23 Sector P/E: 22.43 Dividend Yield: 0% D/E ratio: -

Welcure Drugs And Pharmaceutic Share Price

Sector: Major Drugs

Powered by

12.96 -0.68 (-4.99%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 12.96

Today’s High 12.96

52 Week Low 4.90

52 Week High 15.89

Key Metrics

Market Cap (In Cr) 145.82
Beta 0.62
Div. Yield (%) 0
P/B 1.42
TTM P/E 5.23
Sector P/E 22.43
D/E 0.01
Open Price 12.96
Prev Close 13.64

View All Metrics

Welcure Drugs And Pharmaceutic Analysis

Price Analysis

1 Week

-14.4%
3 Months

42.57%
6 Month

0.31%
YTD

11.05%
1 Year

149.23%

Risk Meter

56% Low risk
56% Moderate risk
56% Balanced Risk
56% High risk
56% Extreme risk

Welcure Drugs And Pharmaceutic Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
24.55

Selling/ General/ Admin Expenses Total
0.28

Depreciation/ Amortization
0.01

Other Operating Expenses Total
2.89

Total Operating Expense
23.68

Operating Income
0.87

Net Income Before Taxes
2.78

Net Income
2.17

Diluted Normalized EPS
0.36

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.15

Total Operating Expense
0.27

Operating Income
-0.27

Net Income Before Taxes
-0.17

Net Income
-0.17

Diluted Normalized EPS
-0.13

Period
2023

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.01

Other Operating Expenses Total
0.11

Total Operating Expense
0.12

Operating Income
-0.12

Net Income Before Taxes
-0.05

Net Income
-0.05

Diluted Normalized EPS
0

Period
2022

Total Revenue
0.11

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.02

Net Income Before Taxes
0.02

Net Income
0.02

Diluted Normalized EPS
0.02

Period
2021

Total Revenue
0.13

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.05

Net Income Before Taxes
0.06

Net Income
0.06

Diluted Normalized EPS
0.05

Period
2020

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.09

Other Operating Expenses Total
0

Total Operating Expense
0.09

Operating Income
-0.01

Net Income Before Taxes
-0.01

Net Income
-0.01

Diluted Normalized EPS
-0.01

Period
2019

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.07

Other Operating Expenses Total
0.01

Total Operating Expense
0.08

Operating Income
0

Net Income Before Taxes
0

Net Income
0

Diluted Normalized EPS
0

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Welcure Drugs And Pharmaceutic Technical

Moving Average SMA

5 Day14.82
10 Day13.98
20 Day12.66

50 Day11.07
100 Day9.93
300 Day10.05

Welcure Drugs And Pharmaceutic Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Ambalal Sarabhai Enterprises
37.35
1.16
3.21
77.7
34.11
286.23

Pharmaids Pharmaceuticals
58.28
-0.67
-1.14
87.46
31.9
205.4

Welcure Drugs And Pharmaceutic
12.96
-0.68
-4.99
15.89
4.9
145.82

Bharat Immunologica And Bio Corp
23.78
-0.16
-0.67
35.88
19
102.42

Ind Swift
18.13
-0.5
-2.68
34.49
12
98.2

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

29-May-25
Audited Results

14-May-25
Others

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

13-Nov-24
Quarterly Results

21-Oct-24
Others

14-Aug-24
Quarterly Results

10-Jun-24
Others

30-May-24
Audited Results

28-Mar-24
Others

Meeting Date
Announced on
Purpose

16-Jun-25
15-May-25
POM

24-Feb-25
23-Jan-25
POM

04-Jan-25
03-Dec-24
POM

30-Sept-24
09-Sept-24
AGM

13-Jul-24
11-Jun-24
POM

28-Sept-23
20-Sept-23
AGM

27-Jun-22
26-May-22
AGM

12-Jul-21
26-May-21
AGM

View All

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

Industry Major Drugs
ISIN INE331C01017
BSE Code 524661

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company operates in one segment, which is the Manufacturing of Steel, Non-Alloys Steel and Alloys Steel Casting.

MANAGEMENT

Chintan Ganpat Chief Financial Officer, Managing Director
Palak Jain Compliance Officer, Company Secretary

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

Welcure Drugs And Pharmaceutic is trading 4.99% lower at Rs 12.96 as compared to its last closing price. Welcure Drugs And Pharmaceutic has been trading in the price range of 12.96 & 12.96. Welcure Drugs And Pharmaceutic has given 11.05% in this year & -14.4% in the last 5 days.

Welcure Drugs And Pharmaceutic has TTM P/E ratio 5.23 as compared to the sector P/E of 22.43.

The company posted a net profit of 2.54 Crores in its last quarter.

Listed peers of Welcure Drugs And Pharmaceutic include Ambalal Sarabhai Enterprises (3.21%), Pharmaids Pharmaceuticals (-1.14%), Welcure Drugs And Pharmaceutic (-4.99%) etc.

Welcure Drugs And Pharmaceutic has a 100% public holding.

FAQs about Welcure Drugs And Pharmaceutic

Welcure Drugs And Pharmaceutic is trading at 12.96 as on 27 Jun, 2025 3:29:23 PM. This is -4.99% lower as compared to its previous closing price of 13.64

The market capitalization of Welcure Drugs And Pharmaceutic is 145.82 Cr as on 27 Jun, 2025 3:29:23 PM.

The 52 wk high for Welcure Drugs And Pharmaceutic is 15.89 whereas the 52 wk low is 4.90

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics -

TTM P/E: 5.23
Sector P/E: 22.43
Dividend Yield: 0%
D/E ratio: -

Welcure Drugs And Pharmaceutic reported a net profit of 2.17 Cr in 2025.

Welcure Drugs And Pharmaceutic Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Welcure Drugs And Pharmaceutic Share Price

Price Range

Key Metrics

Welcure Drugs And Pharmaceutic Analysis

Welcure Drugs And Pharmaceutic Financials

Forecast

Forecast

Forecast

Welcure Drugs And Pharmaceutic Technical

Welcure Drugs And Pharmaceutic Peers

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

MANAGEMENT

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

FAQs about Welcure Drugs And Pharmaceutic

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue